Trial
NCT03381118
Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
St. Petersburg State Pavlov Medical University
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cytarabine
Why stopped
Unexpected toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-05